Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2008

01-04-2008 | SSIEM Symposium 2007

Membrane translocation of glutaric acid and its derivatives

Authors: C. Mühlhausen, B. C. Burckhardt, Y. Hagos, G. Burckhardt, B. Keyser, Z. Lukacs, K. Ullrich, T. Braulke

Published in: Journal of Inherited Metabolic Disease | Issue 2/2008

Login to get access

Summary

The neurodegenerative disorder glutaric aciduria type I (GA I) is characterized by increased levels of cytotoxic metabolites such as glutaric acid (GA) and 3-hydroxyglutaric (3OHGA). The present report summarizes recent investigations providing insights into mechanisms of intra- and intercellular translocation of these metabolites. Initiated by microarray analyses in a mouse model of GA I, the sodium-dependent dicarboxylate cotransporter 3 (NaC3) was the first molecule identified to mediate the translocation of GA and 3OHGA with high and low affinity, respectively. More recently, organic anion transporters (OAT) 1 and 4 have been reported to be high-affinity transporters for GA and 3OHGA as well as d-2- and l-2-hydroxyglutaric acid (D2OHGA, L2OHGA). The concerted action of NaC3 and OATs may be important for the directed uptake and excretion of GA, 3OHGA, D2OHGA and L2OHGA in kidney proximal tubule cells. In addition, experimental data on cultured neuronal and glial cells isolated from mouse brain demonstrated that GA rather than 3OHGA may competitively inhibit the anaplerotic supply of tricarboxylic acid cycle intermediates from astrocytes to neurons. The identification of GA and GA derivative transporters may represent targets for new approaches to treat patients with GA I and related disorders.
Literature
go back to reference Alebouyeh M, Takeda M, Onozato ML, et al (2003) Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 93: 430–436.PubMedCrossRef Alebouyeh M, Takeda M, Onozato ML, et al (2003) Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 93: 430–436.PubMedCrossRef
go back to reference Anzai N, Kanai Y, Endou H (2006) Organic anion transporter family: current knowledge. J Pharmacol Sci 100: 411–426.PubMedCrossRef Anzai N, Kanai Y, Endou H (2006) Organic anion transporter family: current knowledge. J Pharmacol Sci 100: 411–426.PubMedCrossRef
go back to reference Bahn A, Ljubojevic M, Lorenz H, et al (2005) Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol 289: C1075–C1084.PubMedCrossRef Bahn A, Ljubojevic M, Lorenz H, et al (2005) Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol 289: C1075–C1084.PubMedCrossRef
go back to reference Bai X, Chen X, Feng Z, et al (2006) Identification of basolateral membrane targeting signal of human sodium-dependent dicarboxylate transporter 3. J Cell Physiol 206: 821–830.PubMedCrossRef Bai X, Chen X, Feng Z, et al (2006) Identification of basolateral membrane targeting signal of human sodium-dependent dicarboxylate transporter 3. J Cell Physiol 206: 821–830.PubMedCrossRef
go back to reference Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22: 867–882.PubMedCrossRef Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22: 867–882.PubMedCrossRef
go back to reference Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95–158.PubMedCrossRef Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95–158.PubMedCrossRef
go back to reference Burckhardt BC, Lorenz J, Kobbe C, Burckhardt G (2005) Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNaDC-3, under voltage-clamp conditions. Am J Physiol Renal Physiol 288: F792–F799.PubMedCrossRef Burckhardt BC, Lorenz J, Kobbe C, Burckhardt G (2005) Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNaDC-3, under voltage-clamp conditions. Am J Physiol Renal Physiol 288: F792–F799.PubMedCrossRef
go back to reference Busch AE, Karbach U, Miska D, et al (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54: 342–352.PubMed Busch AE, Karbach U, Miska D, et al (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54: 342–352.PubMed
go back to reference Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64: 2312–2318.PubMedCrossRef Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64: 2312–2318.PubMedCrossRef
go back to reference Cha SH, Sekine T, Kusuhara H, et al (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507–4512.PubMedCrossRef Cha SH, Sekine T, Kusuhara H, et al (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507–4512.PubMedCrossRef
go back to reference Funk CBR, Prasad AN, Frosk P, et al (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128: 711–722.PubMedCrossRef Funk CBR, Prasad AN, Frosk P, et al (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128: 711–722.PubMedCrossRef
go back to reference George RL, Huang W, Naggar HA, Smith SB, Ganapathy V (2004) Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse. Biochim Biophys Acta 1690: 63–69.PubMed George RL, Huang W, Naggar HA, Smith SB, Ganapathy V (2004) Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse. Biochim Biophys Acta 1690: 63–69.PubMed
go back to reference Goodman SI, Frerman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2195–2204. Goodman SI, Frerman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2195–2204.
go back to reference Gründemann D, Babin-Ebell J, Martel F, Örding N, Schmidt A, Schömig E (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272: 10408–10413.PubMedCrossRef Gründemann D, Babin-Ebell J, Martel F, Örding N, Schmidt A, Schömig E (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272: 10408–10413.PubMedCrossRef
go back to reference Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A (2007) Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 18: 430–439.PubMedCrossRef Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A (2007) Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 18: 430–439.PubMedCrossRef
go back to reference Hagos Y, Krick W, Braulke T, Mühlhausen C, Burckhardt G, Burckhardt BC (2008) Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias. Pflugers Arch [in press]. Hagos Y, Krick W, Braulke T, Mühlhausen C, Burckhardt G, Burckhardt BC (2008) Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias. Pflugers Arch [in press].
go back to reference Hoffmann GF, Zschocke J (1999) Glutaric aciduria type I: from clinical, biochemical and molecular diversity to succesful therapy. J Inherit Metab Dis 22: 381–391.PubMedCrossRef Hoffmann GF, Zschocke J (1999) Glutaric aciduria type I: from clinical, biochemical and molecular diversity to succesful therapy. J Inherit Metab Dis 22: 381–391.PubMedCrossRef
go back to reference Karbach U, Kricke J, Meyer-Wentrup F, et al (2000) Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279: F679–F687.PubMed Karbach U, Kricke J, Meyer-Wentrup F, et al (2000) Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279: F679–F687.PubMed
go back to reference Kekuda R, Wang H, Huang W, et al (1999) Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter. J Biol Chem 274: 3422–3429.PubMedCrossRef Kekuda R, Wang H, Huang W, et al (1999) Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter. J Biol Chem 274: 3422–3429.PubMedCrossRef
go back to reference Koeller DM, Woontner M, Crnic LS, et al (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11: 347–357.PubMedCrossRef Koeller DM, Woontner M, Crnic LS, et al (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11: 347–357.PubMedCrossRef
go back to reference Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55: 7–12.PubMedCrossRef Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55: 7–12.PubMedCrossRef
go back to reference Kölker S, Garbade SF, Greenberg CR, et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59: 840–846.PubMedCrossRef Kölker S, Garbade SF, Greenberg CR, et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59: 840–846.PubMedCrossRef
go back to reference Kölker S, Garbade SF, Boy N, et al (2007a) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62: 357–363.CrossRef Kölker S, Garbade SF, Boy N, et al (2007a) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62: 357–363.CrossRef
go back to reference Kölker S, Christensen E, Leonard JV, et al (2007b) Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 30: 5–22.CrossRef Kölker S, Christensen E, Leonard JV, et al (2007b) Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 30: 5–22.CrossRef
go back to reference Külkens S, Harting I, Sauer S, et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142–2144.PubMedCrossRef Külkens S, Harting I, Sauer S, et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142–2144.PubMedCrossRef
go back to reference Kusch-Poddar M, Drewe J, Fux I, Gutmann H (2005) Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res 1064: 21–31.PubMedCrossRef Kusch-Poddar M, Drewe J, Fux I, Gutmann H (2005) Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res 1064: 21–31.PubMedCrossRef
go back to reference Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 851–859.PubMedCrossRef Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 851–859.PubMedCrossRef
go back to reference Mühlhausen C, Hoffmann GF, Strauss KA, et al (2004) Maintenance treatment of glutaryl-CoA-dehydrogenase deficiency. J Inherit Metab Dis 27: 885–892.PubMedCrossRef Mühlhausen C, Hoffmann GF, Strauss KA, et al (2004) Maintenance treatment of glutaryl-CoA-dehydrogenase deficiency. J Inherit Metab Dis 27: 885–892.PubMedCrossRef
go back to reference Mühlhausen C, Ott N, Chalajour F, et al (2006) Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res 59: 196–202.PubMedCrossRef Mühlhausen C, Ott N, Chalajour F, et al (2006) Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res 59: 196–202.PubMedCrossRef
go back to reference Pajor AM, Gangula R, Yao X (2001) Cloning and functional characterization of a high-affinity Na+/dicarboxylate cotransporter from mouse brain. Am J Physiol Cell Physiol 280: C1215–C1223.PubMed Pajor AM, Gangula R, Yao X (2001) Cloning and functional characterization of a high-affinity Na+/dicarboxylate cotransporter from mouse brain. Am J Physiol Cell Physiol 280: C1215–C1223.PubMed
go back to reference Peng LA, Schousboe A, Hertz L (1991) Utilization of a-ketoglutarate as a precursor for transmitter glutamate in cultured cerebellar granule cells. Neurochem Res 16: 29–34.PubMedCrossRef Peng LA, Schousboe A, Hertz L (1991) Utilization of a-ketoglutarate as a precursor for transmitter glutamate in cultured cerebellar granule cells. Neurochem Res 16: 29–34.PubMedCrossRef
go back to reference Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101: 16849–16854.PubMedCrossRef Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependent l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101: 16849–16854.PubMedCrossRef
go back to reference Sauer SW, Okun JG, Fricker G, et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97: 899–910.PubMedCrossRef Sauer SW, Okun JG, Fricker G, et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97: 899–910.PubMedCrossRef
go back to reference Schousboe A, Westergaard N, Waagepentersen HS, Larsson OM, Bakken IJ, Sonnewald U (1997) Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia 21: 99–105.PubMedCrossRef Schousboe A, Westergaard N, Waagepentersen HS, Larsson OM, Bakken IJ, Sonnewald U (1997) Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia 21: 99–105.PubMedCrossRef
go back to reference Seijo-Martinez M, Navarro C, Castro del Rio M, et al (2005) l-2-Hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch Neurol 62: 666–670.PubMedCrossRef Seijo-Martinez M, Navarro C, Castro del Rio M, et al (2005) l-2-Hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings. Arch Neurol 62: 666–670.PubMedCrossRef
go back to reference Stellmer F, Keyser B, Burckhardt BC, et al (2007) 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. J Mol Med 85: 763–770.PubMedCrossRef Stellmer F, Keyser B, Burckhardt BC, et al (2007) 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. J Mol Med 85: 763–770.PubMedCrossRef
go back to reference Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet 121C: 38–52.CrossRefPubMed Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet 121C: 38–52.CrossRefPubMed
go back to reference Struys EA (2006) d-2-Hydroxyglutaric aciduria: unravelling the biochemical pathways and the genetic defect. J Inherit Metab Dis 29: 21–29.PubMedCrossRef Struys EA (2006) d-2-Hydroxyglutaric aciduria: unravelling the biochemical pathways and the genetic defect. J Inherit Metab Dis 29: 21–29.PubMedCrossRef
go back to reference Ullrich K, Flott-Rahmel B, Schluff P, et al (1999) Glutaric aciduria type I: pathomechanism of neurodegeneration. J Inherit Metab Dis 22: 392–403.PubMedCrossRef Ullrich K, Flott-Rahmel B, Schluff P, et al (1999) Glutaric aciduria type I: pathomechanism of neurodegeneration. J Inherit Metab Dis 22: 392–403.PubMedCrossRef
go back to reference van der Knaap MS, Jakobs C, Hoffmann GF, et al (1999) d-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity. Ann Neurol 45: 111–119.PubMedCrossRef van der Knaap MS, Jakobs C, Hoffmann GF, et al (1999) d-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity. Ann Neurol 45: 111–119.PubMedCrossRef
go back to reference Wada M, Shimada A, Fujita T (2006) Functional characterization of Na+-coupled citrate transporter NaC2/NaCT expressed in primary cultures of neurons from mouse cerebral cortex. Brain Res 1081: 92–100.PubMedCrossRef Wada M, Shimada A, Fujita T (2006) Functional characterization of Na+-coupled citrate transporter NaC2/NaCT expressed in primary cultures of neurons from mouse cerebral cortex. Brain Res 1081: 92–100.PubMedCrossRef
go back to reference Woontner M, Crnic LS, Koeller DM (2000) Analysis of the expression of murine glutaryl-CoA dehydrogenase: in vitro and in vivo studies. Mol Gen Metab 69: 116–122.CrossRef Woontner M, Crnic LS, Koeller DM (2000) Analysis of the expression of murine glutaryl-CoA dehydrogenase: in vitro and in vivo studies. Mol Gen Metab 69: 116–122.CrossRef
go back to reference Yodoya E, Wada M, Shimada A, et al (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem 97: 162–173.PubMedCrossRef Yodoya E, Wada M, Shimada A, et al (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem 97: 162–173.PubMedCrossRef
go back to reference Zinnanti WJ, Lazovic J, Wolpert EB, et al (2006) A diet-induced mouse model for glutaric aciduria type I. Brain 129: 899–910.PubMedCrossRef Zinnanti WJ, Lazovic J, Wolpert EB, et al (2006) A diet-induced mouse model for glutaric aciduria type I. Brain 129: 899–910.PubMedCrossRef
Metadata
Title
Membrane translocation of glutaric acid and its derivatives
Authors
C. Mühlhausen
B. C. Burckhardt
Y. Hagos
G. Burckhardt
B. Keyser
Z. Lukacs
K. Ullrich
T. Braulke
Publication date
01-04-2008
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2008
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-0825-x

Other articles of this Issue 2/2008

Journal of Inherited Metabolic Disease 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.